BBC

Virtus$38.17-1.60 (-4.02%)
AUM $31.9MER 0.65%NAV $39.87Holdings 198

Price Chart

Key Statistics

Previous Close

$39.77

Day Range

$38.17$39.87

52-Week Range

$35.31$56.02

Avg Volume

63.3K

Dividend Yield

1.54%

Expense Ratio

0.65%

AUM

$31.9M

Shares Outstanding

800.0K

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare100.00%

Country Allocation

CountryWeight %
United States90.49%
Canada2.28%
Netherlands2.02%
United Kingdom1.95%
Ireland1.59%
Switzerland1.06%
China0.61%

Fund Information

Issuer
Virtus
Category
Healthcare
Types
Biotech
Inception Date
Dec 16, 2014
Exchange
NYSE_ARCA
Description
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.

Similar ETFs

SymbolNameAUM
XLVState Street Health Care Select Sector SPDR ETF$46.92B
VHTVanguard Health Care ETF$20.80B
VTWOVanguard Russell 2000 ETF$16.80B
RWLInvesco S&P 500 Revenue ETF$10.01B
XBIState Street SPDR S&P Biotech ETF$9.64B

The Virtus Biotech Clinical Trials ETF (BBC) is an exchange-traded fund issued by Virtus that launched on Dec 16, 2014. It currently manages $31.9M in assets under management. The fund charges an expense ratio of 0.65%. The fund holds 198 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 17.7% of the fund

RankSymbolNameWeight %SharesMarket Value
1KODKodiak Sciences Inc2.41%7,839$767K
2XNCRXencor Inc2.31%21,652$736K
3TRAXFirst Tracks Biotherapeutics Inc2.12%15,135$673K
4REPLReplimune Group Inc1.82%30,064$578K
5ABCLAbCellera Biologics Inc1.68%50,947$533K
6VRDNViridian Therapeutics Inc1.61%16,329$513K
7SLSSELLAS Life Sciences Group Inc1.59%34,097$507K
8AMLXAmylyx Pharmaceuticals Inc1.51%18,298$479K
9SGPSpyGlass Pharma Inc1.40%14,478$446K
10MBXMBX Biosciences Inc1.26%7,519$402K
11LBRXLB Pharmaceuticals Inc1.18%9,394$376K
12ORKAOruka Therapeutics Inc1.17%3,820$373K
13KYMRKymera Therapeutics Inc1.16%3,097$370K
14PRMEPrime Medicine Inc1.16%96,204$369K
15CGONCG Oncology Inc1.15%4,485$367K
Page 1 of 4

Detailed Returns

PeriodReturnETF
1D
-4.02%
1W
-6.61%
1M
-7.45%
3M
-29.52%
6M
-12.04%
YTD
+3.78%
1Y
+5.30%
3Y
+98.72%
5Y
-8.29%

Moving Averages

20-Day MA

$42.31

Below 20-Day MA
50-Day MA

$43.73

Below 50-Day MA
200-Day MA

$45.67

Below 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$56.02

Current Price

$38.17

52-Week Low

$35.31

$35.31$56.02

Current Yield

1.54%

Annual Dividend

$1.2772

Frequency

1x/year

Last Ex-Date

Dec 22, 2025

Dividend History

Ex-DateAmountPay Date
Dec 22, 2025$0.6554Dec 29, 2025
Dec 20, 2024$0.2395Dec 27, 2024
Dec 20, 2023$0.0823Dec 29, 2023
Dec 20, 2017$0.3000Dec 27, 2017
Dec 20, 2017$0.2972Dec 27, 2017
Dec 21, 2015$0.1500Dec 29, 2015
Dec 21, 2015$0.1473Dec 29, 2015

Dividend Payments Over Time

Category Comparison

MetricBBCHealthcare(212 ETFs)Biotech(41 ETFs)
Fund Info
Expense Ratio0.65%0.68%0.86%
AUM$31.9M$842.0M$1.89B
Dividend Yield1.54%5.54%1.97%
Avg Volume63.3K257.4K1.4M
Holdings19812463
Performance
1-Month Return-9.45%-7.05%-8.04%
6-Month Return-6.20%-1.75%+5.24%
YTD Return-1.06%+2.72%+8.75%
1-Year Return-6.88%+0.26%+6.36%

Compare with Another ETF

Search for an ETF to compare with BBC:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.